🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cisplatinum and pemetrexed (ALIMTA®) has become an effective first-line reg...
Status
Unknown
Location
University hospital essen
Start Date
2012-11
Trial ID
NCT01742767
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Hunterdon Regional Cancer Center
Start Date
1999-09
Trial ID
NCT00021333
Treatments Being Tested
The general aim is to compare the cumulative dose of cisplatin administered...
Status
Completed
Location
Centre Paul Strauss
Start Date
2015-12-03
Trial ID
NCT03330249
Treatments Being Tested
This phase II trial employs a prospective, randomized, parallel-group desig...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07609121
Treatments Being Tested
This is a multi-center Phase II study to determine the safety and efficacy ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2018-01-29
Trial ID
NCT03294304
Treatments Being Tested
Standard chemotherapy drugs generally work by killing rapidly dividing cell...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07
Trial ID
NCT00714948
Treatments Being Tested
Purpose: To evaluate the efficacy and safety of neoadjuvant treatment with...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-07-01
Trial ID
NCT07646301
Treatments Being Tested
The purpose of this study is to test the safety of gemcitabine and cisplati...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-08
Trial ID
NCT01182168
Treatments Being Tested
The main objective of this trial was to determine the value of 2 courses of...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-09-20
Trial ID
NCT06492460
Treatments Being Tested
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested